Asthma: Expanding the Medicine Chest
2006

New Treatment for Severe Asthma

Sample size: 17 publication Evidence: moderate

Author Information

Author(s): Szpir Michael

Primary Institution: Southampton General Hospital

Hypothesis

If severe asthma is a Th1 disease, it would respond to a TNF-α blocker.

Conclusion

The treatment with etanercept showed significant improvements in asthma symptoms and lung function for patients with severe asthma.

Supporting Evidence

  • Severe asthma was associated with neutrophils rather than eosinophils.
  • Etanercept treatment led to significant improvements in asthma symptoms and lung function.
  • Previous studies showed no improvement in mild asthma with etanercept.

Takeaway

A new medicine called etanercept might help people with really bad asthma feel better by blocking a certain part of their immune system.

Methodology

The study involved administering etanercept to 17 subjects with severe asthma over 12 weeks.

Limitations

Placebo-controlled studies are needed to fully assess the efficacy of anti-TNF-α therapy.

Participant Demographics

Participants were subjects with severe asthma.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication